Jim Cramer's Market Minute Recap, Dec. 12

Recap of Jim Cramer’s comments on Market Minute from TheStreet.com TV, Tuesday December 12. Click on a stock ticker for more analysis:

Celgene (CELG), Genentech (DNA), Goldman Sachs (GS), Citigroup (C), Core Labs (CLB), Altria (MO), Halliburton (HAL), IBM (IBM) and Texas Instruments (TXN): Cramer says that pharma's malady is spreading to biotech, and nothing seems to be working in these spaces except for Celgene and Genentech which may have a takeover bid because of Avastin, its cancer drug. Overall, Cramer comments that options-expiration scandals are doing strange things to stocks and remarked, "Remember, when you see a Goldman Sachs report a blowout quarter, and there will be no flies in the quarter and the conference call will be good and it's hugging $200, that's what that's about." Cramer thinks that Citigroup's new operating chief Robert Druskin will be able to help the company if "left unfettered," but is concerned that finance Chief Sallie Krawcheck and CEO Charles Prince may hold him back. Cramer found it a little illogical that Texas Instruments was trading at the strike price and is still going up. Concerning oil, Cramer says that recent reports that oil companies are drilling off the Gulf is a "total boon," since the companies can trade independent of oil prices. He picks Core Labs as the chief momentum play and thinks that Halliburton may be worth a second look because it is cheap. He also mentioned Altria and although he isn't too thrilled about IBM, Cramer appreciates its momentum.

Seeking Alpha publishes a summary of Jim Cramer's stock picks every day including: Mad Money Recap, Lightening Round, Stop Trading and his Market Minute.

Get Cramer's Picks by email -- it's free and takes only a few seconds to sign up.

Seeking Alpha is not affiliated with CNBC, Jim Cramer or TheStreet.com